Bliss GVS Pharma Limited

NSEI:BLISSGVS Rapporto sulle azioni

Cap. di mercato: ₹14.6b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Bliss GVS Pharma Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Bliss GVS Pharma ha un patrimonio netto totale di ₹10.0B e un debito totale di ₹998.4M, che porta il suo rapporto debito/patrimonio netto a 10%. Le sue attività totali e le sue passività totali sono rispettivamente ₹12.1B e ₹2.1B. L'EBIT di Bliss GVS Pharma è ₹1.3B rendendo il suo rapporto di copertura degli interessi -23.5. Ha liquidità e investimenti a breve termine pari a ₹1.4B.

Informazioni chiave

10.0%

Rapporto debito/patrimonio netto

₹998.40m

Debito

Indice di copertura degli interessi-23.5x
Contanti₹1.40b
Patrimonio netto₹10.03b
Totale passività₹2.11b
Totale attività₹12.14b

Aggiornamenti recenti sulla salute finanziaria

Recent updates

These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely

Aug 25
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely

Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares

Aug 07
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares

Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now

Jul 19
Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now

Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50

Jul 18
Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50

Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

Jul 04
Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated

May 10
We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated

Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking

Apr 27
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking

Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Feb 20
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding

Jan 26
There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding

Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Jul 14
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50

Sep 11
Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50

Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

Aug 28
Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well

May 21
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well

Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)

Apr 08
Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)

A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns

Mar 18
A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns

Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend

Feb 25
Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend

Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet

Feb 08
Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet

What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?

Jan 21
What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?

Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?

Jan 08
Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?

How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?

Dec 26
How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?

Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?

Dec 13
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?

Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Nov 30
Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings

Nov 18
Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings

Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?

Nov 06
Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?

Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?

Oct 25
Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?

Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Oct 07
Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?

Sep 19
How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( ₹8.1B ) di BLISSGVS superano le sue passività a breve termine ( ₹1.6B ).

Passività a lungo termine: Le attività a breve termine di BLISSGVS ( ₹8.1B ) superano le sue passività a lungo termine ( ₹510.6M ).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: BLISSGVS ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di BLISSGVS si è ridotto da 14.7% a 10% negli ultimi 5 anni.

Copertura del debito: Il debito di BLISSGVS è ben coperto dal flusso di cassa operativo ( 152.7% ).

Copertura degli interessi: BLISSGVS matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.


Bilancio


Scoprire le aziende sane